Abatacept
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01281 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 27 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid vasculitis | KG + DL |
| 2 | ankylosing spondylitis | KG + DL |
| 3 | hypermobility of coccyx | KG + DL |
| 4 | inflammatory spondylopathy | KG + DL |
| 5 | Kummell disease | KG + DL |
| 6 | polyarticular juvenile rheumatoid arthritis | KG + DL |
| 7 | vertebral disease | KG + DL |
| 8 | spondyloarthropathy, susceptibility to | KG + DL |
| 9 | brachydactyly-syndactyly syndrome | KG + DL |
| 10 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 11 | WHIM syndrome | KG + DL |
| 12 | rheumatoid nodulosis | KG + DL |
| 13 | rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | KG + DL |
| 14 | juvenile chronic polyarthritis | KG + DL |
| 15 | mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency | KG + DL |
| 16 | leukoplakia | KG + DL |
| 17 | osteoarthritis susceptibility | KG + DL |
| 18 | psoriasis-related juvenile idiopathic arthritis | KG + DL |
| 19 | bulbar polio | KG + DL |
| 20 | Richter syndrome | KG + DL |
| 21 | familial thrombocytosis | KG + DL |
| 22 | metastatic neoplasm | KG + DL |
| 23 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 24 | malignant spiradenoma | KG + DL |
| 25 | acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | KG + DL |
| 26 | acute lymphoblastic/lymphocytic leukemia | KG + DL |
| 27 | acute myeloid leukemia with t(8;21)(q22;q22) translocation | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.